Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
I just read that back and it’s like the ramblings of s loon. Makes little sense. Made sense at the time.
Anything could happen. Lol.
As far as share price goes, nothing would surprise me next week if still no design freeze news.
We could continue to climb and go into the high 60s.
We could see a sell off on Monday morning as those who qualify for the offer dump 5% of their holding above 40 gambling that it will be replaced at 40. They might not. They might just welcome the chance to get more at 40.
On the 25th the first 7 million placing shares are admitted for trading. There is always a flip for immediate profit element who take placings, irrespective of news. Their strategy is just to take the profit and move on so there could be a churn of placing stock on Wednesday.
In anticipation of this, certain traders in the market will exit on Tuesday afternoon so they don’t get caught in a drop due to churn on Monday.
Or we could just hang fire and stay here. No idea. I’ll be holding all my current stock, taking my allocation and I’ve topped up cash on my account so if there is a sell off on mon/tues/wed for any reason, I can buy the dips.
We know design freeze is coming but it will be volatile now until news with so many influences in play.
GLA.
Prior to the raise there was a lot of money on the sidelines, basically thinking it was coming because of the cash position and expansion plans.
That risk now removed and market has realized it is unlikely to go lower so risk off money now piling in.
Doubtlessly there’ll be the usual small trader sell off on Monday morning if no news followed by the afternoon recovery as we’ve seen.
No idea where the range could be though. Wouldn’t be surprised if it settles in high 60s of even 70s now prior to news.
Lots more risk removed and design Freeze now highly likely. It’s more a matter of when, not if.
Well these bumps in the road are annoying but sometimes necessary.
Whatever happens with the SP in the next few weeks the only fundamental change is that we now have more shares in issue but the cash required to fully implement the expansion plans.
The target for my by year end remains at £280-£300mill Mcap. The resultant share price will now of course be lower due to this dilution but this remains my target and is 3X Mcap today.
AVCT are currently sat at £325Million Mcap with no tests and nothing but some liquid that test manufacturers might be able to use if they can get it to work. Omega are in a much better place, hence the much lower placing and surety of success.
I always said that all omega have to do is make 50Million tests a year as planned under the expansion and the Mcap will eventually reflect that value.
I take a long term view and I’ll be here for the year and won’t be derisking until I hit my Mcap target.
I’ll be applying for 15,000 placing shares at 40p under my allocation allowance as I currently hold about 310,000 today so onwards and upwards.
I’m not too happy with the way it was done but that’s the bent game unfortunately and it isn’t worth whining about. I prefer to look forward.
Good luck everyone who stays in and let’s just see if we don’t crack that quid over the summer!
GLA.
Bantu - It just means “No Trade” meaning the broker isn’t letting you buy live online because *they say* they don’t have enough stock available to satisfy your order. They make you put in a limit order or fill or kill above the advertised ask and just keep taking the price up, like an auction. If your bid isn’t high enough your order doesn’t get filled. They sell your stock back to you at a much higher price. They rinse you.
If you listened to and acted on baseless rumour yesterday and you want to buy back in today then that is going to cost you money. Your money will go into the pockets of the Market Makers.
They will make it very difficult to buy back in today where you sold out yesterday. They need to make cash so they will make the stock NT to buy, keep taking it up until they’ve rinsed all the wet mugs who ****ed the bed yesterday over a picture of Banksy and a few bell ends with 10 followers on twatter.
Good luck. Put some dry pyjamas on today ;)
Not necessarily. You’re obviously poor for a reason.
Imo the hold has been while a decision was made on direction.
The partners could well be now to announce Design freeze and move on to the next stages.
https://www.mirror.co.uk/news/politics/breaking-government-abandons-nhs-coronavirus-22213932
BBC breaking news is that gov have abandoned the NHSX contact tracing app and are adopting the google/Apple app.
It could be this f c k wittery that is holding things up and the partners are simply embarking on more large scale validation surveys while gov get their act together.
We are definitely further along than we are being told and imo held up by gov shenanigans.
U.K. gov in talks to use facial recognition tech on immunity passports....
https://www.businessinsider.com/coronavirus-uk-in-talks-with-id-startups-over-immunity-passports-2020-4
Seeking alpha put out this piece in 2016 to value the rapid medical test kit market globally at $30Billion.
With the massive increase in demand from Covid, expect multiples of that in coming months/years.
https://seekingalpha.com/article/3943876-rapid-medical-testing-kits-are-huge-market
I’m not saying there will be. I’m saying there should be this is price sensitive information released by an official consortium partner that finished, manufactured tests are being used by the general public. That’s price sensitive. It’s already caused a spike in the share price and half of the market who do not use twitter or these boards are unaware why. That’s what the RNS system was designed to guard against.
If this news had been tweeted by Abingdon would you expect t omega to follow with an official news release? Of course.
This is every bit as valid. Ulster uni are in the consortium.
Half the market are aware tests are being used and half aren’t. That’s a disorderly market. Market abuse. Simple as that.
The company should release an RNS today to explain what’s happening either way to inform investors who do not use social media. It is remiss of them not to. That is the “Regulatory” system.
Ulster uni are now an official member of the RTC. Tara Moore is an official advisor. This is an official release of consortium price sensitive information and every bit as valid as if it had come from Abingdon. Market now open. Some shareholders aware, some not. That’s what the RNS system is designed to guard against.
What part of “Regulatory News System” don’t you understand.
I have said for weeks that they are in production and further along than we are being told. That situation allowed under cover of government confidentiality. This proves it. They’re producing the tests already....
Somebody forgot to tell Tara about price sensitive information....
Tara Moore, Genome Editor Professor of personalized medicine at Ulster University.
Find out if you have antibodies to the virus that causes COVID-19 the day you attend our study. We are using the UK-RTC COVID-19 lateral flow antibody test #beatcoronavirus @UlsterUniBiomed @nibec_research @mlchealth @UUEngineering @GiveBloodNI
https://twitter.com/tara_moore7/status/1272593385522692097?s=21
Immunity passports will be introduced within months.
Instead of worthlessly moaning on this board your course of action is to put your objections in writing to your local mp.
Good luck with it.
Immunity passports are coming and will be part of the new normal by year end in my opinion.
This opinion strengthened by continually googling the term to monitor the increase level of global noise around them and the increasing number of companies working on tech from USA to India to Israel.
Even a story now about a German company called IdNow working with the UK government to perfect an ID verification app that would verify an immunity identification card and link through to the nhs app. Google it you’ll find it.
An increasing level of editorials and comment on the entire philosophy around immunity passports and reports from Israel that they are looking at developing sterile areas in airports for use by passengers with antibodies.
Immunity passports are coming. Mass antibody testing will be essential. Omega and the U.K. biotech industry will have the only rapid test that is 98%+ accurate and capable of fulfilling this function.
Rapid Antibody testing + Immunity Passports = The New Normal.
GLA. Have a google and DYOR.
Rather than rubbish posted by traders and hack journalists. If you want to know what the scientists findings are on immunity then read the key findings at the end of the scientific paper I posted on the 14th. Here it is again.....
Coronavirus antibody immunity scientific paper14 Jun 2020 06:57
“A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease“
“Key findings:
We have presented a broad, comprehensive review of multiple aspects of the literature on antibody immunity to coronaviruses. We identified a number of key findings. The median time to detection was similar across different antibodies for SARS-CoV-1 (12 days; IQR 8-15.2 days) and SARS-CoV-2 (11 days; IQR 7.25-14 days), but longer for MERS-CoV (16 days; IQR 13-19 days). Most long-term studies found that IgG waned over time (typically detectable up to at least a year) while others found detectable levels of IgG three years post symptoms onset. Antibody kinetics varied across the severity gradient with longer durations of detectable antibody associated with more severe symptoms. Human challenge studies with HCoV indicate that serum and mucosal immune responses (serum IgG, IgA, neutralizing titer, mucosal IgA) provide possible correlates of protection from infection and disease. However, repeat human challenge experiments with single HCoV suggest individuals can be infected with the same HCoV one year after first challenge, but with possible lower severity. There is cross-reactivity within but minimal reactivity between Alpha- and Beta-CoVs. While endemic HCoVs rarely induce cross-reactive antibodies against emerging HCoVs, SARS-CoV-1 and MERS-CoV stimulate antibodies induced by prior HCoV infections.”
https://www.medrxiv.org/content/10.1101/2020.04.14.20065771v1.full.pdf
Design freeze RNS likely to be an intraday press release by Abingdon as was the last RTC trading update, with a simultaneous Omega RNS.
This intermittent stage is not what the public will be interested in so can’t see it being announced at the briefing until PHE approval and order signed off further down the track.
Intraday is my guess.
Futures Tumble Below 3,000 After China Warns Of "High Virus Resurgence Risk"....
https://www.zerohedge.com/markets/futures-tumble-below-3000-after-china-warns-high-virus-resurgence-risk
Scientific paper post was 06:57
Worth a read for anybody seriously interested in the value of antibody testing and the likelihood of immunity and how long it lasts.
GLA